Eli Lilly's U.S. stock pre-market rose over 14% after the company released research data on weight loss medication

華爾街見聞
2025.04.17 10:56

禮來美股盤前直線拉昇，現漲超 14%，公司稱減肥藥 Orforglipron 在 3 期臨牀試驗中達到主要終點。

公司 IR 網站：

Source: 華爾街見聞 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.